8
Participants
Start Date
September 1, 2017
Primary Completion Date
September 1, 2023
Study Completion Date
September 1, 2023
Intraductal secretin test (IDST)
If pancreatic duct entry incidentally occurs during the clinically scheduled ERCP and the pancreatic duct appears normal, an IDST will be performed for study purposes. An IDST consists of the administration of human secretin, after which pancreatic juice is collected intraductally. In this study, the fluid will be collected through continuous aspiration in 5 minute intervals for 30 minutes. Samples will be collected at 5, 10, 15, 20, 25, and 30 minutes after secretin administration (6 collections in total).
Indiana University, Indianapolis
Indiana University
OTHER